Heart Disease, Clinical Proteomics and Mass Spectrometry
Heart disease is the leading cause of mortality and morbidity in the world. As such, biomarkers are needed for the diagnosis, prognosis, therapeutic monitoring and risk stratification of acute injury (acute myocardial infarction (AMI)) and chronic disease (heart failure). The procedure for biomarker...
| Main Authors: | , , , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
IOS Press
2004
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3839266/ |